'Absolute risk' presentation slideshows

Clinical Epidemiology

1.57k views • 123 slides

Coronary Heart Disease Medication

944 views • 85 slides

Predicting risk of cardiovascular disease and the cost-effectiveness of interventions in Thailand

Predicting risk of cardiovascular disease and the cost-effectiveness of interventions in Thailand Stephen Lim On Behalf of the Setting Priorities using Information on Cost-Effectiveness (SPICE) Project. MALE. FEMALE. Rank. Disease category. DALYs. %. Disease category. DALYs. %. 1.

568 views • 43 slides

Risk Analysis

Risk Analysis. Topics. - Risk and Uncertainty - General Risk Categories - Probability - Probability Distributions - Payoff Matrix - Expected Value - Variance and Standard Deviation (Measurement of Absolute Risk)

844 views • 41 slides

Evidence-based stroke medicine, past present and future

650 views • 40 slides

Spatial Science & Health

Spatial Science & Health. Health data Issues Dr Mark Cresswell. Topics. Who compiles health data? Medical ethics Anonymised case records Disease summary statistics Problems: human Problems: technical Examples of public-access health data. Who compiles Health Data?.

530 views • 38 slides

Intro to Evidence Based Medicine (EBM)

Wipanee Phupakdi, MD September 15, 2010. Intro to Evidence Based Medicine (EBM). Overview. Define EBM Learn steps in EBM process Identify parts of a well-built clinical question Discuss resources for literature search Critical appraisal of the evidence Apply to the patient

2.63k views • 36 slides

PP (Study Design) for 2 nd Year

PP (Study Design) for 2 nd Year. Dave Garbera F1 Arrowe Park Hospital. Learning Objectives. Population Measures Study Design Statistical Devices Problems with Analysis Sensitivity, Specificity and Positive Predictive Value. Why PP?.

482 views • 35 slides

Absolute cardiovascular disease risk

Absolute cardiovascular disease risk. Assessment and Early Intervention. Dr Michael Tam Lecturer in Primary Care m.tam@unsw.edu.au. Aim. To demonstrate the clinical application of absolute cardiovascular disease (CVD) risk assessment. Learning objectives.

523 views • 29 slides

DISCLAIMER

DISCLAIMER. Menopausetoday gives the following presentation for your information and to promote discussion. We welcome your comments We advise you if you have concerns to consult your doctor or local health department for further information. .

441 views • 26 slides

Microeconomics 2

Microeconomics 2. John Hey. Chapters 23, 24 and 25. CHOICE UNDER RISK Chapter 23: The Budget Constraint. Chapter 24: The Expected Utility Model. Chapter 25: Exchange in Markets for Risk Remember the Health Warning: this is one of my research areas...

382 views • 26 slides

Using evidence in practice

359 views • 22 slides

QCancer qcancer Professor Julia Hippisley-Cox

QCancer www.qcancer.org Professor Julia Hippisley-Cox. Professor of Clinical Epidemiology & General Practice Professorial Fellow St Annes , Oxford GP Woodstock Director QResearch (non-profit collaboration with EMIS Health) Director ClinRisk Ltd (software company).

552 views • 21 slides

SEXUAL ACTIVITY AND SEXUAL DYSFUNCTION IN PATIENTS WITH HEART DISEASE

SEXUAL ACTIVITY AND SEXUAL DYSFUNCTION IN PATIENTS WITH HEART DISEASE. DR EBRAHIM NEMATIPOUR CARDIOLOGIST AND PROFESSOR OF TEHRAN UNIVERSITY OF MEDICAL SCIENCES. SEXUAL ACTIVITY AND SEXUAL DYSFUNCTION IN PATIENTS WITH HEART DISEASE. SUBJECTS.

442 views • 21 slides

Risk Perception

1.96k views • 17 slides

FAST STATS

FAST STATS. A 5-minute Review for the Evidence-Based Practitioner. When evaluating medical literature, there are two important concepts absolute risk vs. relative risk number needed to treat. Absolute Risk & Relative Risk.

283 views • 15 slides

Statistics for nMRCGP

Statistics for nMRCGP. Jo Kirkcaldy. Curriculum Condensed Knowledge. Incidence and prevalence Specificity and sensitivity Positive and negative predictive values Absolute risk and absolute risk reduction Relative risk and relative risk reduction NNT and NNH Odds and odds ratio

315 views • 15 slides

RISK STRATIFICATION

RISK STRATIFICATION. Risk Stratification Guidelines. Established by the CACR in Sept. 1999 National Guidelines Committee

322 views • 12 slides

Current & New treatment strategies to address CV Risk

221 views • 10 slides

David M. Shlaes Anti-infectives Consulting, LLC Stonington, CT

David M. Shlaes Anti-infectives Consulting, LLC Stonington, CT. Participation sponsored by: Nabriva, Vienna, AU Novexel, Romainville, FR Consulting relationships with a number of biotechnology companies or investment firms working in the area of antiinfective discovery and development. .

576 views • 6 slides